Today CMPI helped with the formal launch of IGuard.org, the first personalized drug safety tool developed for consumers and created by consumers that will tell, in real time, what drugs are working best for what people. iGuard provides patients with free medication safety checks, personalized safety alerts and updates, and the opportunity to share medication experiences with others. And, by monitoring outcomes across its user community, iGuard can help the FDA and other researchers identify problems faster than ever. Who will benefit from iGuard. Consumers who want to learn more about how the medicines, vitamins and supplements they are taking or plan to take will affect them as individuals. Drug companies should want to get involved to learn sooner rather than later about the consumer's experience with a drug, including how they are benefitting, drug-drug interactions, drug-disease interactions, as well as companies who want to communicate with consumers about ways to improve their experience with a medicine. It's a much better way to communicate with customers than through meta-analysis conducted by Steve Nissen.
IGuard is a free service to anyone who signs up and use of information for research purposes is confidential and voluntary.
Registration is free online at www.iGuard.org.